Physician profile
Li Che
NPI 1801327978
$2,602.84
in general payments reported to CMS, 2019-2025
10 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $1,393 · 2023: $14.63 · 2024: $137 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,162.90 | 2022 | |
| Saluda Medical Americas, INC. | $354.56 | 2025 | Evoke |
| Biotronik Nro, INC. | $211.02 | 2025 | Prospera |
| Globus Medical, INC. | $196.89 | 2025 | Senza |
| Nalu Medical, INC. | $146.78 | 2021 | |
| Fisher & Paykel Healthcare INC | $137.45 | 2024 | Fisher & Paykel Healthcare |
| Medtronic, INC. | $127.85 | 2021 | |
| Nevro Corp. | $124.77 | 2022-2023 | Senza |
| Grt US Holding, INC. | $120.45 | 2022 | |
| Spr Therapeutics, INC | $20.17 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Li Che listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.